Oslo bystyre vedtok onsdag 18. desember å selge flere eiendommer til Oslo Science Hub. Dette åpner for en utvidelse av Campus Radiumhospitalet. Salget består av fire eiendommer, og det vil åpne for mer kreftforskning og utvikling av ny kreftbehandling.
A new grant will speed up the manufacturing of new cell therapies for personalised medicine in Norway.
DoMore Diagnostics is addressing a significant challenge in the treatment of colorectal cancer (CRC).
Nine countries met in Oslo last week to discuss how to establish National Cancer Mission Hubs in their respective EU member states or associated countries.
EXACT Therapeutics is preparing to launch a phase II clinical trial in pancreatic cancer with funds from a recent private placement.
Well-known companies and intriguing newcomers in the cancer field were featured at the DNB conference this week.
Get monthly news updates and invitations to events from our oncology cluster.
New buildings and labs are being planned with the environment in mind.
The 30th BIO-Europe gathered the global health and biotech industry for Europe’s largest partnering meeting in Stockholm.
Vi savner konkrete tiltak som kan hjelpe gründere i regjeringens nye stortingsmelding om gründere og oppstartsbedrifter.
HealthCatalyst will support Norwegian companies with advice, networks and activities to strengthen their position in the German healthcare market, as a part of the government's export reform.
Lung cancer experts emphasised the need for improved screening protocols to enhance early detection and reduce mortality rates across the Nordic region.
Artificial intelligence brings endless opportunities, but can it contribute to tackling healthcare challenges caused by a rapid aging population and an increase in complex disease?
